CURLF · Curaleaf Holdings, Inc.
AI read · Good for CURLF
The AI's read
Curaleaf publicly proposed buying Aurora for roughly $4 a share, offering 0.3463 Curaleaf shares plus $0.75 cash per Aurora share. The deal would create a pro forma company near $3 billion with about $1.5B revenue and roughly $350M Adjusted EBITDA. CURLF barely moved on the news, down 0.6% with RSI around 47, so the market has not priced a big re-rate yet. Aurora gets a roughly 45% premium and the Aurora board has so far declined talks, so execution risk is real. We lean bullish on CURLF because the offer meaningfully scales Curaleaf and cites at least $40M in annual cost saves. Confidence 90% — fresh, company-specific catalyst, but regulatory and integration risk remain material.